Patents Assigned to Naegis Pharmaceuticals Inc.
  • Leukotriene synthesis inhibitors
    Patent number: 11976052
    Abstract: Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions.
    Type: Grant
    Filed: January 10, 2020
    Date of Patent: May 7, 2024
    Assignee: Naegis Pharmaceuticals Inc.
    Inventors: David L. Burgoyne, Erin DeBruin, Julia Fonarev, James Gee Ken Yee, John Michael Langlands
  • LEUKOTRIENE SYNTHESIS INHIBITORS
    Publication number: 20220064132
    Abstract: Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions.
    Type: Application
    Filed: January 10, 2020
    Publication date: March 3, 2022
    Applicant: Naegis Pharmaceuticals Inc.
    Inventors: David L. Burgoyne, Erin Debruin, Julia Fonarev, James Gee Ken Yee, John Michael Langlands